Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 53OTHER_GOV 5NIH 3FED 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 385Specimen Handling 370Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Interventional × Simvastatin × Clear all
NCT02968810 2026-05-04

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT01110785 2013-09-17

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
46 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01190462 2013-08-12

Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
51 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡